NDRI Presents Empowering Research and Discovery Award to Washington Regional Transplant Community, Recognizing Outstanding Commitment to Advancing Research.
The Board of Directors of the National Disease Research Interchange (NDRI) is pleased to announce that Dr. Katalin Karikó and Dr. Drew Weissman, the scientists who led the research and technology development for the therapeutic use of mRNA – the foundation for the COVID vaccines developed by Pfizer/BioNTech and Moderna/NIH, will receive NDRI’s 2022 Empowering Research and Discovery Award. Click here to read more
NDRI CAP Accreditation
-Philadelphia-based National Disease Research Interchange (NDRI) announces the election of Paul M. Lieberman, Ph.D., to its Board. Lieberman is the Hilary Koprowski, M.D., Endowed Professor, leader of the Gene Expression and Regulation Program, and director of the Center for Chemical Biology & Translational Medicine at The Wistar Institute, a biomedical research leader in cancer, immunology, infectious disease, and vaccine development. Elected on November 12 to a three-year term, Lieberman will bring his experience and insight to the nation’s leading source of human organs, cells and tissues for research.
The National Disease Research Interchange (NDRI) is pleased to announce its recovery network partners for the developmental Genotype-Tissue Expression (dGTEx) project. The dGTEx project is the first comprehensive public resource correlating gene expression and genetic variation in pediatric tissues from all major organ systems in the human body. NDRI will partner with multiple organ procurement organizations/tissue banks across the United States.
NDRI and collaborators were awarded a research grant of $12.5M over 5 years to collaborate on the developmental Genotype Expression (dGTEx) project
NDRI was recently awarded a research resource grant of $334,446 from the National Institute on Aging (NIA) to support the development of the Ocular Tissue Resource for Alzheimer’s Disease (OTRAD). While significant advances continue to be made with the identification of blood-based biomarkers for Alzheimer’s disease (AD), there is an emergent interest in the use of ocular imaging or other ocular biomarkers as a parallel approach in early detection of the disease.
NDRI issued a public comment on the Centers for Medicare and Medicaid Services proposed rule entitled "Medicare Program: Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long Term Care Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2022 Rates; Quality Programs and Medicare Promoting Interoperability Program Requirements for Eligible Hospitals and Critical Access Hospitals; Proposed Changes to Medicaid Provider Enrollment". This rule dramatically discourages the use and acquisition of human tissues for biomedical research- our comment was posted on June 22. You can read the full submission on our website here: https://ndriresource.org/uploads/attachments/ckqgogkpsedvv96u16sf1qfss-ndripubliccomment.pdf
In early January 2021, NDRI’s Scientific Services and Marketing teams sent out a 10- question survey to approximately 3,000 researcher contacts. We have received a very strong and insightful 11% response.
NDRI is pleased to share our Spring 2021 edition of Research Nexus. Inside you will find findings from our COVID-19 Researcher Survey, stories and publications from our researchers, updates on our programmatic initiatives and staff, and highlights featuring some of our very own board members.
Read this edition and look for highlights of our stories in the days ahead!
Throughout NDRI’s 40-year history, we have partnered with more than 130 tissue source sites, including organ procurement organizations, tissue banks, eye banks and hospitals to provide some 500 scientists annually from across the globe with human specimens to advance research toward treatments and cures to improve the lives of patients and their families — without these partnerships NDRI’s mission simply would not be possible.
NDRI is proud to share a series of videos highlighting our partners, researchers and those who make the fulfillment of NDRI's mission possible!
View our researcher highlights:
The National Disease Research Interchange (NDRI), a world leader in the procurement and distribution of biospecimens to advance research, recognized Donor Network West, an Organ Procurement Organization (OPO) which serves northern California and northern Nevada, as the recipient of the second annual NDRI/AOPO Empowering Research and Discovery Award for outstanding commitment to the advancement of research.
Thank you for being a part of the NDRI Community. NDRI’s Board of Directors and leadership team has made the decision to postpone our 40th Anniversary Service to Science Dinner in Philadelphia, PA on November 12, 2020, due to growing uncertainty surrounding the current and evolving COVID19 outbreak.
NDRI is proud to announce the second annual NDRI & AOPO Empowering Research and Discovery Award will be presented virtually at the Association of Organ Procurement Organizations - AOPO the week of June 22.
This award recognizes an organ procurement organization committed to advancing research. Nominations will be accepted through June 1, 2020. The NDRI and AOPO Research and Discovery Award will be presented to an organ procurement organization for their work with NDRI and commitment to research broadly. Nominate your OPO here:
In this special edition of NDRI's Research Nexus, learn about the valuable partnerships and programs that have shaped NDRI's 40-year-old mission, how we have grown from supporting diabetes research to serving researchers around the world with tissues and organs for research on multiple diseases, and our plans to celebrate this year's milestone.
The National Disease Research Interchange (NDRI) has been awarded a research grant of $275,000 to continue to support efforts of the National Institutes of Mental Health (NIMH) and the Office of Director of the National Institutes of Health (NIH) aimed at furthering the research of the causes and behavioral associations with individuals diagnosed with Autism Spectrum Disorder (ASD). NDRI has been consistently supported by the NIH to support Autism research since 2016.
We are pleased to announce the relocation of NDRI’s offices! Our new address is:
Three Parkway, 1601 Cherry Street, Suite 1700, Philadelphia PA 19102
NDRI continues to monitor the spread of COVID-19 in the US and the actions being taken by our transplant partners (the federally designated organ procurement organizations), as required or recommended by federal regulatory and oversight bodies including the Eye Bank Association of America, American Association of Tissue Banks, FDA, and CDC.
Thomas J. Bell, MS, PhD promoted to Senior Vice President, Strategic Intiatives and Melissa VonDran, PhD promoted to Vice President, Operations & Director, Biorepository.
Learn more about our leadership: NDRI Executive Management Team
The Board of Directors and staff of the National Disease Research Interchange are thrilled to honor Susan Hockfield, PhD, President Emerita and Professor of Neuroscience, Massachusetts Institute of Technology with our D. Walter Cohen, DDS, Service to Science Award at our 40th Anniversary Service to Science Awards Dinner.